Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

Phase 3 N=25 Ketamine to Prevent PPD After Cesarean

Postpartum Depression
Primary: The Prevalence of Postpartum Depression in the Study Population, as Defined as EPDS Greater Than 10 Out of 30 — 4; 2; 5 Participants
Washington University School of Medicine Results Jan 2023 0.0% serious AE View details

Phase 4 N=300 Ketamine for Acute Pain Management After Trauma

Trauma Injury · Pain · Opioid Use
Primary: Average Daily Opioid Use as Measured by the Morphine Milligram Equivalents (MME) Per Day — 32; 39 MME per day
The University of Texas Health Science Center… Results Apr 2023 0.0% serious AE View details

Phase 2 N=16 Ketamine for Suicidality in Bipolar Depression

Bipolar Disorder · Major Depressive Episode · Suicidal Ideation
Primary: Change in Suicidal Ideation Measured With the Beck Scale for Suicidal Ideation — -12.4; -6.7 units on a scale
New York State Psychiatric Institute Results Jun 2019 25.0% serious AE View details

Phase 4 N=24 Ketamine For Suicidal Ideation

Suicidal Ideation
Primary: Change in Beck Scale for Suicidal Ideation (BSSI) — 10.8; 14.0 units on a scale — p=0.32
James Murrough Results Feb 2017 20.8% serious AE View details

Phase 4 N=16 Ketamine for Depression: An MRI Study

Depression · Anxious Depression · Major Depressive Disorder
Primary: Change in Hamilton Depression Rating Scale (HDRS) From Baseline/Minute 0 to 4 Hours Post-infusion. — -9.625 score on a scale — p=<0.01
Massachusetts General Hospital Results Apr 2019 0.0% serious AE View details

Phase 3 N=33 Ketamine for Treatment Resistant Late-Life Depression

Treatment Resistant Depressive Disorder
Primary: Percentage of Participants Demonstrating at Least a 50% Reduction on Montgomery-Asberg Depression Rating Scale Scores — 0; 2; 8; 6 Participants
VA Office of Research and Development Results Aug 2021 3.0% serious AE View details

Phase 2 N=12 Ketamine and Prolonged Exposure in PTSD

Post-traumatic Stress Disorder
Primary: Change in Severity of Post-traumatic Stress Disorder (PTSD) Symptoms — 15.3 units on a scale
Minneapolis Veterans Affairs Medical Center Results Mar 2021 0.0% serious AE View details